Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 31, 2025
allGeo, a Service by Abaqus Inc., Enhances Its End-to-End Field Workflow Automation Capabilities
EIN Presswire
·
March 31, 2025
allGeo enhances field service automation with scheduling, advanced time …
Intrinseque Health Receives Award for Best Clinical Development Supply Chain Solutions Partner 2025
EIN Presswire
·
March 31, 2025
Intrinseque Health Secures Prestigious Recognition for the Fourth Consecutive Year SINGAPORE, SINGAPORE, March 31, 2025 /EINPresswire.com/ -- Intrinseque Health has achieved yet another milestone for the fourth time in a row, being awarded the Best …
The Good Feet Store Re-Opens in Louisville, Helping Local Residents and Workforce Live the Life They Love
EIN Presswire
·
March 31, 2025
The Leading Retailer of Premium, Personally-Fitted Arch Supports Expands with the Opening of its Relocated Louisville Location LOUISVILLE, KY, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- The Good Feet Store, recognized nationally as the market- …
First Responder Neurofeedback, Inc. Launches Nationwide to Enhance Mental Health and Well-Being for First Responders
EIN Presswire
·
March 31, 2025
Jennifer Tierney Appointed as Executive Director to Lead Strategic Planning and Program Development DENVER, CO, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- First Responder Neurofeedback, Inc., a nonprofit organization committed to supporting the …
Ayushman Hair Centre Launches New Website for Hair Restoration Services
EIN Presswire
·
March 31, 2025
NEW DELHI, DELHI, INDIA, March 31, 2025 /EINPresswire.com/ -- Ayushman Hair Centre, a leading hair restoration clinic, has recently launched a new website to provide a convenient and accessible platform for their clients. The website offers a wide range …
Boon-Chapman Strengthens Leadership Team with Appointment of New General Counsel
EIN Presswire
·
March 31, 2025
AUSTIN, TX, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- Boon-Chapman, a leader in claims administration, cost containment, and care navigation, is pleased to announce the appointment of Tim McConville as General Counsel, effective March 31, 2025. …
Planet TV Studios ‘New Frontiers’ Episode on Mirion Technologies, Accelerating Advancements in Precision Medicine, Airing Q2 2025: The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios
EIN Presswire
·
March 31, 2025
Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. Mirion Technologies, Inc. in New Frontiers Episode Airing Q2 2025 on Bloomberg. ATLANTA, GA, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- Planet TV Studios is …
Biomed Industries CEO to Chair NeuroSciences 2025 and Present Breakthrough Research on Alzheimer’s Disease and Obesity
EIN Presswire
·
March 31, 2025
Biomed Industries, Inc. CEO to Chair NeuroSciences 2025 and Present Groundbreaking Research on Alzheimer’s, Obesity, and Rett Syndrome SAN JOSE, CA, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- Biomed Industries, Inc. (Biomed) announced today …
Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market
GlobeNewswire
·
March 31, 2025
BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES BY 29% LAUNCHED NEW STATE OF THE ART VIVID WORKSTATION Investor Call to be held Tuesday, April 1st at 11:00 a.m. Eastern Time …
Total number of shares and voting rights in Zealand Pharma as of March 31, 2025
GlobeNewswire
·
March 31, 2025
Company announcement – No. 8 / 2025 Total number of shares and voting rights in Zealand Pharma as of March 31, 2025 Copenhagen, Denmark, March 31, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a …
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
March 31, 2025
Transformational 2024: successfully advanced from preclinical to clinical stage company Strengthened leadership team to drive growth and advance clinical development Investigational Device Exemption (IDE) approval for continuous blood glucose monitoring ( …
Bavarian Nordic modtager FDA-godkendelse af frysetørret koppe- og mpoxvaccine
GlobeNewswire
·
March 31, 2025
KØBENHAVN, Danmark, 31. marts 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at de amerikanske lægemiddelmyndigheder, U.S. Food and Drug Administration (FDA) har godkendt den frysetørrede version af vaccinen JYNNEOS® til forebyggelse af kopper og …
Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine
GlobeNewswire
·
March 31, 2025
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS® (Smallpox and Mpox Vaccine, Live, Non-replicating) for prevention …
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
March 31, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
GlobeNewswire
·
March 31, 2025
PRINCETON, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host a fireside chat at the 2025 RBC Capital Markets …
Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
GlobeNewswire
·
March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its …
VAXIL’s Annual and Special Shareholders Meeting
GlobeNewswire
·
March 31, 2025
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), announces that at the Company's Annual and Special General Meeting, held virtually, …
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 31, 2025
Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing Preparations for Phase 1/2 clinical trial in Australia …
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
GlobeNewswire
·
March 31, 2025
NEW HOPE, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing …
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
GlobeNewswire
·
March 31, 2025
Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc …